---
report: Citation Audit — Section 12 (Implementation Plan), Pass 3 (independent)
section: 12
run_date: 2026-07-24
reviewer: evidence-citation-agent (independent Pass 3 — no memory of drafting or of the Pass 2 fix session)
source_file: vault/Projects/Business_Plan_Drafts_v2/Section_12_Implementation_Plan.md
verdict: FAIL
---

# Citation Audit — Section 12 (Implementation Plan) — Pass 3

Fresh trace of every numeric/named-fact claim in the current file, plus a from-source re-derivation of
`DEC-009`'s actual resolved text (read in full, not assumed from the Pass 2 fix note's summary), the
`Investment_Options_Register.md` entry, and `OPT-002`/`OPT-003`'s own option records.

## Part A — DEC-009 ground truth (read directly)

`vault/Decisions/Decision_Log/DEC-009_investment-options-ranking-and-allocation-priority.md`:
- Frontmatter: `status: approved`, `resolved_date: "2026-07-23"`.
- "Decision" section, verbatim: **"Resolved 2026-07-23, by direct user/team instruction (middle path).
  Both open questions are now settled"** — funding sequence: "YES, commit to one... OPT-002 and OPT-003
  as the near-term, low-risk/high-fit priority; OPT-001 and OPT-005 continue-at-pace; OPT-004 as the
  longer-horizon build." **DEC-009 is not unresolved anywhere in its own record.**
- The earlier "Tiering (descriptive grouping...)" sub-section (lines 88-95) is explicitly labeled
  draft-stage/descriptive and puts OPT-003 alone in "Tier 2," separate from OPT-002's "Tier 3" — this is
  the sub-section a mis-sequenced draft would cite if it stopped reading at the comparison framework
  instead of the resolved Decision below it. The Decision section supersedes this for sequencing
  purposes; the Tiering sub-section remains valid only as the underlying evidence-strength grouping.
- `OPT-003`'s own record confirms alignment: "Not a pilot — this is an already-evidenced,
  already-operating mechanism... Recommend a targeted budget weighting toward these three markets
  **within the existing bucket**" — a near-term action, matching DEC-009's Decision text, not the
  isolated Tier-2 grouping.
- `Investment_Options_Register.md` line 47-49 confirms: "the tiering (OPT-002/OPT-003 near-term
  priority, OPT-001/OPT-005 continue-at-pace, OPT-004 longer-horizon) is now the plan's citable
  recommended funding sequence."

**Conclusion: DEC-009 is resolved/approved, and OPT-003's correct current sequencing status is near-term
priority alongside OPT-002 (not H2-gated monitoring-only, not Tier-2-isolated).**

## Part B — Section 12's current text against this ground truth

| # | Claim (as currently drafted) | Cited to | Verified against | Result |
|---|---|---|---|---|
| 1 | Provenance note: "`DEC-009` is **resolved** (`status: approved`, 2026-07-23, middle path)" | `DEC-009` | Matches DEC-009 frontmatter/Decision section exactly | **PASS** — the previously-flagged "unresolved" claim is gone; no residual instance of "unresolved" found anywhere in the file (checked by direct search) |
| 2 | "Answer, stated first": OPT-002 and OPT-003 named as "the near-term priority pair"; OPT-003 "an already-evidenced, already-operating mechanism... that DEC-009 and its own option record both recommend funding immediately, not gating behind a pilot" | `DEC-009` | Matches DEC-009's Decision text and OPT-003's own record verbatim ("Not a pilot... targeted budget weighting... within the existing bucket") | **PASS** — the previously-flagged H2-gated-monitoring-only mis-sequencing is corrected; OPT-003 is now placed as a funded-now, near-term item, not deferred |
| 3 | H1: OPT-001/OPT-005 "continue at pace... no new decision" | `DEC-009`; `KPI_Tree_v2.md` | OPT-001/OPT-005 records both self-describe as "already-scaling, already-funded" / "already yielding disclosed results" | PASS |
| 4 | H1: OPT-002 "cheapest and most reversible... GCC/Group evidence is most explicitly an inference" | `ASM-016`, DEC-009 | ASM-016: Low confidence, Approved; DEC-009 comparison table confirms High reversibility/Low evidence for OPT-002 | PASS |
| 5 | H1: OPT-003 "Fund now, within the existing bucket... -4% y/y non-high-value M1 retention, is real and current — TLB-019, page 9" | TLB-019 p.9 | Confirmed: "Q4'25 y/y M1 retention change by segment (competitive markets): high-value +6%, non-high-value -4%" (p.9), scoped explicitly to "competitive markets: UAE, Kuwait, Qatar" | PASS — figure and geography both verified, correctly not extended to Egypt/Group |
| 6 | H1: OPT-003 action includes "establishing a formally documented dry-powder deployment trigger (currently absent)" | implicit, OPT-003 record | OPT-003 Pilot recommendation: "plus a formally documented dry-powder deployment trigger (currently absent) rather than an open-ended reserve" | PASS |
| 7 | **H2: "`OPT-003` review... if not, this is the point at which a Decision Log entry proposing incremental Food-leadership spend (beyond the disclosed ~USD55mn) would need to be raised"** | Not cited inline; no traceability-table row | `OPT-003_food-leadership-cvp-partner-retention-gcc3.md` "Recommended allocation range": **"USD 25-32mn (base) / USD 32-40mn (upside, dry powder deployed) / USD 15-22mn (downside), *within the Food-leadership bucket*."** The option record's own upside case — the one that explicitly models dry-powder deployment — stays inside the disclosed ~USD55mn bucket (max ~40mn of ~55mn), leaving headroom. `Food Leadership.md`'s Open Questions confirm the corpus never states dry powder is *additional to* the ~USD55mn total; that is an assumption Section 12 introduces on its own. | **FAIL.** This is a numeric-magnitude claim (that a future ask could exceed the total disclosed programme bucket) with no citation and no support in the very option record (`OPT-003`) that governs this decision's sequencing — in fact contradicted by it, since OPT-003's own dry-powder-deployed upside scenario is constructed to stay within the ~55mn bucket. Fix: either cite a source that actually supports "beyond ~USD55mn," or reword to something the record supports, e.g. "...a Decision Log entry proposing a shift toward the upside end of OPT-003's within-bucket allocation range (or, if that proves insufficient, a request beyond the disclosed ~USD55mn envelope) would need to be raised." |
| 8 | H2: OPT-002 go/no-go gated on "the GCC+Jordan cohort's 20-28%/26-32% range" | `ASM-016` | ASM-016 states these figures explicitly (Approved, Low confidence); also appear in OPT-002's own Evidence section | PASS |
| 9 | H2: OPT-004 begins, "the ~7%-of-GMV UAE benchmark is a multi-period target, not a quick win" | Traceability table: `Topics/Advertising.md`; TLB-001, page 21 | `20260331_talabat-Annual-Report-2025...txt` (TLB-002 source text): "In the UAE, for example, advertising technology margins have already reached 7% of GMV for talabat mart." `TLB-001` source note: "global benchmark target ~7% of GMV medium-term (TLB-001, p.13, p.20-21)." Figure and UAE-only scoping both confirmed genuine and correctly labeled country-specific, not Group. | PASS — the Pass 2 "minor" citation-completeness gap (no inline/table citation) has been fixed: the traceability table now carries this row with `Topics/Advertising.md`; TLB-001, page 21 |
| 10 | H3: OPT-003 "already funded from H1... whether the incremental-spend question it may have raised was resolved" | — | Restates claim #7's premise without adding a new citation | Carries forward the same unsupported "incremental spend" framing as #7 — not an independent new defect, but not independently fixed either |
| 11 | "Dependencies and Timelines": KPI Tree's Governance family "none of which currently has a baseline" | `KPI_Tree_v2.md` | "Governance family: 7 KPIs — 0 baseline-exists, 7 newly-instrumented" | PASS |
| 12 | "the same one flagged in Section 2.2: no market-level allocation logic is disclosed anywhere in the corpus" | `Capital Allocation and Investment Governance.md` | Topic note Open Questions confirm this; cross-check against Section 2.2 problem 3 holds | PASS |
| 13 | Traceability table row: "OPT-002 cheapest, most reversible \| DEC-009" | `DEC-009` | Verified (see #4) | PASS |
| 14 | Ancillary: `OPT-002` talabat pro GMV-share date label | — | `OPT-002_talabat-pro-acceleration-egypt-iraq.md` lines 12 and 23 now both read **"Q1 2025 → Q1 2026"** (not the stale "FY2024 → Q1 2026" Pass 2 flagged). Repo-wide grep for the stale pattern finds it only in historical Validation-report prose describing the defect, not in any live content file. | **PASS** — the ancillary repo-wide date-label fix did land for `OPT-002`, and no live recurrence found elsewhere in files this section cites |

## Geographic Evidence Rules check

All country-specific claims in the current text (OPT-002 → Egypt/Iraq inferred-applicability; OPT-003 →
UAE/Kuwait/Qatar country-specific/market-comparison; OPT-004 → UAE-specific benchmark applied as a
Group-level inference) carry their qualifiers correctly and match the tags in the underlying `OPT-`
records and `Geographic_Evidence_Rules.md`. No un-qualified geography transfer found in this pass.

## Verdict

**FAIL.** Both defects Pass 2 found (the stale "DEC-009 unresolved" claim, and OPT-003's mis-sequencing
as H2-gated monitoring-only) are confirmed genuinely fixed on independent re-derivation of DEC-009's own
resolved text — no regression, no residual instance of either defect anywhere in the file. The ancillary
`OPT-002` date-mislabeling fix also landed correctly. **However, this fresh full-claim trace surfaces one
new, independent defect not previously flagged:** claim #7 (H2's "incremental Food-leadership spend
(beyond the disclosed ~USD55mn)" framing) is an uncited numeric-magnitude claim that is actually
contradicted by `OPT-003`'s own recommended allocation range, whose dry-powder-deployed upside case is
explicitly constructed to stay within the disclosed ~USD55mn bucket. Per the 0%-tolerance rule for
untraceable numeric claims, this must be fixed (reworded or given a supporting citation that does not
exist in the current corpus) before Section 12 can clear to Stage 10. Claim #10 (H3) restates the same
unsupported framing and should be checked/reworded alongside #7 in the same pass.
